Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences. - Wikidata - wikimedia - TriplyDB

Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences.

Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences.

http://www.wikidata.org/entity/Q45353014

about

Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.Viral surveillance and subclinical viral infection in pediatric kidney transplantation.Peripheral Blood Epstein-Barr Viral Nucleic Acid Surveillance as a Marker for Posttransplant Cancer Risk.Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.Epstein-Barr virus infection in adult renal transplant recipients.The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children.Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study.Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.Detection of Epstein-Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications.Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.The role of CMV and EBV renal allograft loss--reply.The role of CMV and EBV in renal allograft loss.BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study

P2860

Q26998832-2D57BDEA-4DF2-43CD-ADC2-9EF670323A22 Q33874038-008373E7-B559-4C30-80D9-7939ACE8FB6E Q35106937-06C67351-112B-4BBD-A464-3F27E59E9664 Q38240085-5399DBC5-1072-41FF-8579-FF6DE85E421C Q38908687-A6D19AB8-72FA-4ECE-9BAC-5B93706255C4 Q39091657-00BA551B-CAE2-4E9F-8125-15AAB165989B Q39194877-BDEC7EA1-B55A-4E8A-9D29-86D6CAEDC94C Q39311630-9954C1D6-9EF5-42DE-89AE-969050A5FBCE Q39321579-125A0995-6D9A-4B5B-BDD6-40DF183669AA Q39386528-45411C76-573A-41C3-8821-8D1B83190FDD Q40358580-2F0858E5-0565-449F-B8F0-CC49F6225A5D Q40628228-D982EB83-4BCB-4A91-BDBD-3F285E1C494B Q40630330-F5E1247F-6C1E-4AEE-A2FF-7F2CB200C1D0 Q40721769-E4928971-EEB6-4A3C-8BFE-E07312C4C1B1 Q42278126-E117D7E9-2009-4DAF-88B3-DF9EB73858D5 Q51869720-FFE97E25-A685-4421-9A38-4422E95DA1EA Q51870875-7BB44AC6-8FE0-418D-ACFB-9D964450F2EF Q56957209-9A4DED81-FAE4-4BE5-A1F7-60BC4BFAEE49

P2860

Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences.

http://www.wikidata.org/entity/Q45353014

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Subclinical Epstein-Barr virus ...... s: incidence and consequences.

@en

Subclinical Epstein-Barr virus ...... s: incidence and consequences.

@nl

type

label

Subclinical Epstein-Barr virus ...... s: incidence and consequences.

@en

Subclinical Epstein-Barr virus ...... s: incidence and consequences.

@nl

prefLabel

Subclinical Epstein-Barr virus ...... s: incidence and consequences.

@en

Subclinical Epstein-Barr virus ...... s: incidence and consequences.

@nl

P1433

Q45353014-ECD7FEAC-A96A-4BA3-8090-F39A42CB22EF

P1476

Q45353014-226DBB6E-581A-489A-B49A-71BC75078D5C

P2093

Q45353014-458B0B9B-5DA9-429A-A87D-DDFC83554AD8

Q45353014-622B0313-8F68-4F9E-90AE-6279708D779B

Q45353014-A50EA3A4-2C73-4469-92E9-D64393AD55BF

Q45353014-A922A12A-A881-4B68-A280-25FA1F30E9FF

Q45353014-B57BB9B7-7DBE-4BDF-B43C-23838B13D515

Q45353014-E44A84F4-61A8-4CD9-AD18-4E0E50A29751

Q45353014-EF824A97-BA50-4EDA-92FF-D45A3DF017F1

P2860

Q45353014-18DC8349-F17D-4E73-9107-09BC41708B36

Q45353014-26882DA2-26E0-4FEC-B1EC-DE933AAEC549

Q45353014-2BBBD590-4892-4E99-B391-119DB7E54B89

Q45353014-33A7AF59-1106-4C6E-BCC9-8CF2A4240F91

Q45353014-4B1DA9F8-B89E-4327-964C-F5D2021192EF

Q45353014-51320A30-B204-4422-B4DE-6425C67FE12E

Q45353014-7127D333-AC22-4F04-AB27-707E269EB128

Q45353014-877BEF49-A197-4747-BDEF-00A1A8A7B9CF

Q45353014-8C444351-98F0-4F28-B49B-7329BC6F70B7

Q45353014-B587D423-3B40-48CB-8A67-5DE95FB1B1F1

P304

Q45353014-E883FF4F-8849-4460-AC66-41425A3DB07B

P31

Q45353014-AF252EDF-8B28-412B-B5AE-4B62B9F8534A

P356

Q45353014-7D5C4C77-D3A6-45BE-A9AC-2D0239F2070C

P407

Q45353014-ACF16779-B4E4-4DD1-85DD-5E21DDFD68C5

P433

Q45353014-BB27831B-C6A3-40F9-9AFD-761D45D9C687

P478

Q45353014-C6D29210-0829-4E4D-912C-D3E3E605C955

P577

Q45353014-6A254E71-EA32-490F-8678-BD5DD5749749

P5875

Q45353014-4973C92D-4D5A-42AF-AAFA-6E33319AC77E

P698

Q45353014-4EB5DBE1-E414-4135-8A6E-4AF6ED465F87

P356

P1433

American Journal of Transplantation

P1476

Subclinical Epstein-Barr virus ...... s: incidence and consequences.

@en

P2093

A Coaquette

http://www.w3.org/2001/XMLSchema#string

C Courivaud

http://www.w3.org/2001/XMLSchema#string

D Ducloux

http://www.w3.org/2001/XMLSchema#string

E Gaiffe

http://www.w3.org/2001/XMLSchema#string

J Bamoulid

http://www.w3.org/2001/XMLSchema#string

J-M Chalopin

http://www.w3.org/2001/XMLSchema#string

P Saas

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.

Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients.

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.

Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.

Epstein-Barr virus DNA load in peripheral blood mononuclear cells and whole blood from pediatric transplant recipients.

Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients.

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.

Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil.

P304

656-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.12009

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234696031

http://www.w3.org/2001/XMLSchema#string

P698

23331474

http://www.w3.org/2001/XMLSchema#string